CellaVision AB (publ) (CLVSF)
OTCMKTS · Delayed Price · Currency is USD
19.28
-0.63 (-3.16%)
At close: Jan 23, 2025

Accolade Statistics

Total Valuation

CellaVision AB has a market cap or net worth of 419.82 million. The enterprise value is 406.91 million.

Market Cap419.82M
Enterprise Value 406.91M

Important Dates

The last earnings date was Friday, July 18, 2025.

Earnings Date Jul 18, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 23.85M
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 19.82M

Valuation Ratios

The trailing PE ratio is 26.41 and the forward PE ratio is 22.49.

PE Ratio 26.41
Forward PE 22.49
PS Ratio 5.31
PB Ratio 4.85
P/TBV Ratio 12.89
P/FCF Ratio 20.83
P/OCF Ratio 19.35
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.27, with an EV/FCF ratio of 20.19.

EV / Earnings 25.59
EV / Sales 5.25
EV / EBITDA 17.27
EV / EBIT 20.00
EV / FCF 20.19

Financial Position

The company has a current ratio of 3.19, with a Debt / Equity ratio of 0.04.

Current Ratio 3.19
Quick Ratio 2.28
Debt / Equity 0.04
Debt / EBITDA 0.13
Debt / FCF 0.16
Interest Coverage 30.75

Financial Efficiency

Return on equity (ROE) is 19.35% and return on invested capital (ROIC) is 15.05%.

Return on Equity (ROE) 19.35%
Return on Assets (ROA) 12.30%
Return on Invested Capital (ROIC) 15.05%
Return on Capital Employed (ROCE) 21.45%
Revenue Per Employee 345,086
Profits Per Employee 69,424
Employee Count219
Asset Turnover 0.75
Inventory Turnover 2.00

Taxes

In the past 12 months, CellaVision AB has paid 4.18 million in taxes.

Income Tax 4.18M
Effective Tax Rate 20.81%

Stock Price Statistics

The stock price has increased by +15.31% in the last 52 weeks. The beta is 1.22, so CellaVision AB's price volatility has been higher than the market average.

Beta (5Y) 1.22
52-Week Price Change +15.31%
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 45.66
Average Volume (20 Days) 535

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, CellaVision AB had revenue of 79.02 million and earned 15.90 million in profits. Earnings per share was 0.67.

Revenue79.02M
Gross Profit 54.39M
Operating Income 20.73M
Pretax Income 20.08M
Net Income 15.90M
EBITDA 22.76M
EBIT 20.73M
Earnings Per Share (EPS) 0.67
Full Income Statement

Balance Sheet

The company has 16.33 million in cash and 3.17 million in debt, giving a net cash position of 13.16 million.

Cash & Cash Equivalents 16.33M
Total Debt 3.17M
Net Cash 13.16M
Net Cash Per Share n/a
Equity (Book Value) 86.54M
Book Value Per Share 3.63
Working Capital 29.36M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 21.70 million and capital expenditures -1.55 million, giving a free cash flow of 20.15 million.

Operating Cash Flow 21.70M
Capital Expenditures -1.55M
Free Cash Flow 20.15M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 68.83%, with operating and profit margins of 26.24% and 20.12%.

Gross Margin 68.83%
Operating Margin 26.24%
Pretax Margin 25.40%
Profit Margin 20.12%
EBITDA Margin 28.80%
EBIT Margin 26.24%
FCF Margin 25.50%

Dividends & Yields

CellaVision AB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 39.44%
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 3.79%
FCF Yield 4.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 7